A critical role is uncovered for intrinsically disordered regions (IDRs) in activating NLRP1, NLRP3, and NLRP14 inflammasomes, suggesting that targeting the dynamics of phase transitions could open novel therapeutic avenues for treating inflammatory and autoimmune diseases.
Abstract
Inflammasomes are multiprotein complexes that orchestrate immune responses to pathogenic and sterile insults by regulating the maturation of inflammatory cytokines and pyroptotic cell death. While inflammasome activation is well-characterized at the biochemical level, the mechanisms governing the spatial and temporal assembly of these complexes remain poorly understood. Here, we uncover a critical role for intrinsically disordered regions (IDRs) in activating NLRP1, NLRP3, and NLRP14 inflammasomes. Through structural prediction analyses, we identify IDRs within these receptors that harbor post-translational modification sites essential for inflammasome assembly and function. Notably, disease-associated mutations in NLRP1 and NLRP3 occur within these IDRs, underscoring their functional relevance in inflammatory disorders. Our computational analysis suggests that IDR-mediated phase separation may drive inflammasome condensation at the perinuclear membrane, serving as a sensor for cellular stress, as stress signals may change their conformation, through post-translational modifications, and thus their interaction capacity. Furthermore, inflammasomes lacking IDRs in their NLRPs may rely on interactions with chaperone or adapter proteins containing IDRs for proper assembly. These insights provide a new framework for understanding the regulation of inflammasomes, suggesting that targeting the dynamics of phase transitions could open novel therapeutic avenues for treating inflammatory and autoimmune diseases.
Cryogenic-electron microscopy structures of human NLRP6 monomer in the adenosine-5'-triphosphate (ATP)/NBD-bound (twisted conformation) and unbound (extended conformation) states reveal the ATP-mediated cooperative inhibition mechanism of NLRP6 and provide insight into the therapeutic intervention of NLRP6-related auto...
Zhen Cui, Qi Sheng, Minsoo Son et al.· Nature Structural & Molecula...· 0 citations
The NLRP3 inflammasome is a cytoplasmic multiprotein complex that is activated under stress or infection conditions. It promotes the maturation of IL-1β by cleaving pro-Caspase-1, thereby playing a critical role in host innate immune responses. Various viruses can differentially activate NLRP3 through distinct mechanis...
Li-Fang Cao, Run-Bin Huang, Lu Yang et al.· Fish and Shellfish Immunolog...· 0 citations
Vilazodone exerted anti-inflammatory effects in vivo, reducing cytokine production in mouse models of MSU-induced peritonitis and LPS-induced systemic inflammation and highlight its potential for repurposing in inflammasome-driven diseases.
Xiang-Yu Yang, Gui-Fang Xiong, Jie Yang et al.· International Immunopharmaco...· 0 citations
Recent advances in the understanding of the molecular mechanisms that mediate interactions between NLRP3 and other inflammasome-associated pathways are summarized, focusing on shared signaling components, organelle dynamics, posttranslational modifications, and feedback regulatory circuits.
Nan-Yang Xiao, Ze-Xuan Lu, D. Cooper et al.· Cellular & Molecular Immunol...· 0 citations
Although targeted modulation of inflammasome pathways represents a promising therapeutic strategy, further research is needed to refine patient selection, identify reliable biomarkers, and better characterise disease heterogeneity to enable successful clinical translation.
Caroline Neumann, Florian Hickl, Julia Kemnitzer et al.· Critical Care· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.